Delivery Order SPE2DB24D3014-SPE2DB25FKULM
Award Date 8/25/25
Potential Completion Date 8/26/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Insulin Degludec Pen (U-100) 3ML pharmaceutical products with a ceiling value of $1,157.57. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and represents a child contract issued under a larger vehicle. The contract was awarded competitively without set-aside designation, and performance will be executed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Insulin Degludec Pen (U-200) 3ML with a ceiling value of $3,634.43 under a firm fixed-price contract type. The award, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Insulin Degludec Pen (U-200) 3ML with a ceiling value of $1,471.13. This contract, which was competitively awarded without set-aside designation, carries a firm fixed price structure and is categorized as a delivery order with an ultimate completion date of July 22, 2025. The award was made to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters and place...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,385.42 on August 19, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10mL). This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation. The place of...
- The U.S. Department of Defense (DOD) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,184,917 units of Insulin Degludec Pens (U-200) 3ML. The contract, valued at $4,137.57, has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of insulin degludec pens (U-100), 3 mL, with a firm fixed price and a ceiling value of $1,158.51. The contract has an ultimate completion date of July 1, 2025. This contract is not set aside and was awarded on June 30, 2025. AmerisourceBergen Drug Corp is the prime contractor and...
- The U.S. Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,463.20 for Insulin Aspart 100 Unit/mL vials (10mL) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Insulin Aspart 100 Unit/ML pens (3ML) with a ceiling value of $9,672.58. This firm fixed price delivery order, which is not associated with a set-aside program, represents a competitive procurement to support federal medical supply needs. The order is scheduled for completion by August 14, 2025, and will be fulfilled from AmerisourceBergen's corporate office located in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,962.88 firm-fixed-price delivery order is for the supply of insulin degludec pens (U-200, 3mL) to support military healthcare programs. The contract has an ultimate completion date of January 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,710.72 firm fixed price contract is for the supply of insulin degludec pens (U-100, 3 mL) to support military treatment facilities and federal healthcare programs. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently...